McManus Matthew bought TECH
February 1, 2024 · Form 4 insider transaction
McManus Matthew bought 13,861 shares of Bio-Techne Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
13,861
Price
$0.00
Total value
N/A
InsiderMcManus Matthew
Role—
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateFebruary 1, 2024
Filing dateFebruary 5, 2024
Shares owned after13,861
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.; 4,620 restricted stock units vest on 2/1/2025 and 2/1/2027, and 4,621 restricted stock units vest on 2/1/2026.